Internal Medicine: Nephrology: Vinod K. Bansal, MD | Loyola Medicine

Vinod K. Bansal, MD

Medicine

Nephrology
Professor
Medical Director, Chronic Dialysis

Languages Spoken

English, Hindi

Clinical Expertise

  • Nephrolithiasis
  • Peritoneal Dialysis
  • Polycystic Kidney Disease
  • Renal Disease (Kidney Disease)
  • Systemic Lupus Erythematosus
  • Vasculitis

About Dr. Bansal

Interests
Golf, Jogging, Foreign movies, Travel, Reading

Medical Education

Medical School
University of Rajasthan, India
Residency
SMS Medical College
India - Internal Medicine: General
University of Illinois at Chicago Medical Center - Internal Medicine: General
Fellowship
  • University of Colorado School of Medicine - Internal Medicine: Nephrology
  • Cedars-Sinai Medical Center - Internal Medicine: Nephrology
  • New York University Medical Center - Internal Medicine: Nephrology

Board Certification

American Board of Internal Medicine
American Board of Internal Medicine Subspecialty Nephrology

Research

  • Biomarkers of Endothelial Renal, and Platelet Dysfunction in Stage 5 Chronic Kidney Disease Hemodialysis Patients With Heart Failure, McMillan, R.; Skiadopoulos, L.; Hoppensteadt, D.; Guler, N.; Bansal, V.; Parasuraman, R.; Fareed, J., Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • Biomarker profiling of plasma samples for various diseases utilizing RANDOX Biochip Array Technology Saluk, J.; Hoppensteadt, D.; Syed, D.; Liles, J.; Abro, S.; Walborn, A.; Bansal, V.; Fareed, J., International angiology : a journal of the International Union of Angiology
  • Biomarkers of Endothelial Renal, and Platelet Dysfunction in Stage 5 Chronic Kidney Disease Hemodialysis Patients With Heart Failure, McMillan, R.; Skiadopoulos, L.; Hoppensteadt, D.; Guler, N.; Bansal, V.; Parasuraman, R.; Fareed, J., Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
View All ResearchShow Less
  • Inflammatory and Metabolic Syndrome Biomarker Analysis of Vascular Outcomes in End-stage Renal Disease Sweigert, P. J.; Bansal, V. K.; Hoppensteadt, D. A.; Saluk, J. L.; Syed, D. A.; Fareed, J., The International journal of angiology : official publication of the International College of Angiology, Inc
  • KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD), Isakova, T.; Nickolas, T. L.; Denburg, M.; Yarlagadda, S.; Weiner, D. E.; Gutierrez, O. M.; Bansal, V.; Rosas, S. E.; Nigwekar, S.; Yee, J.; Kramer, H., American Journal of Kidney Diseases : The Official Journal of the National Kidney Foundation
  • Non-dialysis dependent chronic kidney disease is associated with high total and out-of-pocket healthcare expenditures Small, C.; Kramer, H. J.; Griffin, K. A.; Vellanki, K.; Leehey, D. J.; Bansal, V. K.; Markossian, T. W., BMC Nephrology
  • Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report Bansal, V. K.; Herzog, C. A.; Sarnak, M. J.; Choi, M. J.; Mehta, R.; Jaar, B. G.; Rocco, M. V.; Kramer, H., American Journal of Kidney Diseases : The Official Journal of the National Kidney Foundation
  • Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey) Bress, A. P.; Kramer, H.; Khatib, R.; Beddhu, S.; Cheung, A. K.; Hess, R.; Bansal, V. K.; Cao, G.; Yee, J.; Moran, A. E.; Durazo-Arvizu, R.; Muntner, P.; Cooper, R. S., Circulation
  • Controversies Regarding Lipid Management and Statin Use for Cardiovascular Risk Reduction in Patients With CKD Markossian, T.; Burge, N.; Ling, B.; Schneider, J.; Pacold, I.; Bansal, V.; Leehey, D.; Stroupe, K.; Chang, A.; Kramer, H., American Journal of Kidney Diseases : The Official Journal of the National Kidney Foundation
  • Effect of erythropoietin stimulating agents on vascular endothelial growth factor levels in patients with end stage renal disease Saluk, J. L.; Bansal, V.; Hoppensteadt, D.; Syed, D.; Abro, S.; Fareed, J., International angiology : a journal of the International Union of Angiology
  • Urinary incontinence and diuretic avoidance among adults with chronic kidney disease Patel, M.; Vellanki, K.; Leehey, D. J.; Bansal, V. K.; Brubaker, L.; Flanigan, R.; Koval, J.; Wadhwa, A.; Balasubramanian, N.; Sandhu, J.; Kramer, H., International Urology and Nephrology
  • Immunoenzymatic and Biochip Array Profiling of the Biomarkers of Inflammation and Hemostatic Activation Processes in ESRD Richards, J.; Bansal, V.; Iqbal, O.; Hoppensteadt, D.; Fareed, J., Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • Neurologic Complications of Chronic Kidney Disease Vellanki, K.; Bansal, V. K., Current neurology and neuroscience reports
  • Prevalence of metabolic syndrome in patients with end stage renal disease and relevance of biomarkers Saluk, J.; Bansal, V.; Hoppensteadt, D.; Syed, D.; Abro, S.; Fareed, J., International angiology : a journal of the International Union of Angiology
  • Progressive increase of inflammatory biomarkers in chronic kidney disease and end-stage renal disease Sharain, K.; Hoppensteadt, D.; Bansal, V.; Singh, A.; Fareed, J., Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • Variations in the circulating heparin levels during maintenance hemodialysis in patients with end-stage renal disease Kaneva, K.; Bansal, V.; Hoppensteadt, D.; Cunanan, J.; Fareed, J., Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • Upregulation of surrogate markers of inflammation and thrombogenesis in patients with ESRD: pathophysiologic and therapeutic implications. Nelson, K.; Thethi, I.; Cunanan, J.; Hoppensteadt, D.; Bajwa, R.; Fareed, J.; Bansal, V., Clinical & Applied Thrombosis/Hemostasis
  • Increased prevalence of antiheparin platelet factor 4 antibodies in patients may be due to contaminated heparin. Adiguzel, C.; Bansal, V.; Litinas, E.; Cunanan, J.; Iqbal, O.; Nelson, K.; Kannan, M.; Hoppensteadt, D.; Fareed, J., Clinical & Applied Thrombosis/Hemostasis
  • Structural and functional characterization of low-molecular-weight heparins: impact on the development of guidelines for generic products. Adiguzel, C.; Jeske, W. P.; Hoppensteadt, D.; Walenga, J. M.; Bansal, V.; Fareed, J., Clinical & Applied Thrombosis/Hemostasis
  • Contaminant in the recalled unfractionated heparin preparations: where is the problem?. Hoppensteadt, D. A.; Wahi, R.; Adiguzel, C.; Iqbal, O.; Ramacciotti, E.; Bick, R. L.; Messmore, H. L.; Bansal, V.; Fareed, J., Clinical & Applied Thrombosis/Hemostasis
  • Erythropoietin-induced thrombosis as a result of increased inflammation and thrombin activatable fibrinolytic inhibitor. Tobu, M.; Iqbal, O.; Fareed, D.; Chatha, M.; Hoppensteadt, D.; Bansal, V.; Fareed, J., Clinical & Applied Thrombosis/Hemostasis
  • Medical nutrition therapy in chronic kidney failure: integrating clinical practice guidelines Beto, J. A.; Bansal, V. K., Journal of the American Dietetic Association
  • Nutrition interventions to address cardiovascular outcomes in chronic kidney disease Beto, J. A.; Bansal, V. K., Advances in Chronic Kidney Disease